The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience

Drug-resistant tuberculosis (DR-TB) threatens to derail tuberculosis control efforts, particularly in Africa where the disease remains out of control. The dogma that DR-TB epidemics are fueled by unchecked rates of acquired resistance in inadequately treated or non-adherent individuals is no longer...

Full description

Saved in:

Bibliographic Details
Published in:	The Lancet infectious diseases Vol. 24; no. 9; pp. e559 - e575
Main Authors:	Naidoo, Kogieleum, Perumal, Rubeshan, Cox, Helen, Mathema, Barun, Loveday, Marian, Ismail, Nazir, Omar, Shaheed Vally, Georghiou, Sophia B, Daftary, Amrita, O'Donnell, Max, Ndjeka, Norbert
Format:	Journal Article
Language:	English
Published:	United States Elsevier Ltd 01.09.2024 Elsevier Limited
Subjects:	Antitubercular Agents - therapeutic use COVID-19 Disease control Disease resistance Disease transmission Drug resistance Epidemics Epidemiology Humans Innovations Medical diagnosis Medical innovations Mycobacterium tuberculosis - drug effects Pandemics Patients Poverty Quality of life South Africa - epidemiology Tuberculosis Tuberculosis, Multidrug-Resistant - diagnosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology Tuberculosis, Multidrug-Resistant - transmission South Africa Mozambique Africa
ISSN:	1473-3099, 1474-4457, 1474-4457
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!